Peripheral inflammation and neuroprotection: systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease.

Peripheral inflammation and neuroprotection: systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease.

Item
http://www.wikidata.org/entity/Q34571775
Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunityRANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's DiseaseBCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease.Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease.Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease.Microglial phenotypes in Parkinson's disease and animal models of the disease.Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat.Targets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments.α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology.Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats.Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.Role of Neuron-Glial Interaction Mediated by IL-1β in Ectopic Tooth Pain.Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease.
P2860

Peripheral inflammation and neuroprotection: systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease.

Item
http://www.wikidata.org/entity/Q34571775
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Peripheral inflammation and ne ...... model of Parkinson's disease.
@ast
Peripheral inflammation and ne ...... model of Parkinson's disease.
@en
Peripheral inflammation and ne ...... model of Parkinson's disease.
@nl
type
label
Peripheral inflammation and ne ...... model of Parkinson's disease.
@ast
Peripheral inflammation and ne ...... model of Parkinson's disease.
@en
Peripheral inflammation and ne ...... model of Parkinson's disease.
@nl
prefLabel
Peripheral inflammation and ne ...... model of Parkinson's disease.
@ast
Peripheral inflammation and ne ...... model of Parkinson's disease.
@en
Peripheral inflammation and ne ...... model of Parkinson's disease.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Peripheral inflammation and ne ...... model of Parkinson's disease.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921